Erin Chapple
Known title: DirectorCIK: 0001901052
Associated companies
Transaction History
| PCOR | ▲ Buy | Grant | 4,712 | $0 | 6/4/2026 | View on chart |
| PCOR | ▲ Buy | Grant | 3,049 | $0 | 6/5/2025 | View on chart |
| PCOR | ▲ Buy | Grant | 2,887 | $0 | 6/6/2024 | View on chart |
| PCOR | ▲ Buy | Grant | 3,574 | $0 | 6/7/2023 | View on chart |
| PCOR | ▲ Buy | Grant | 5,333 | $0 | 12/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Procore Shares Rise After Cantor Overweight Endorsement
Cantor Fitzgerald reaffirmed its overweight stance on Procore Technologies, keeping a $65 price target. The stock has risen in the market, trading above its 200‑day moving average and near the support level at $55.26. Analysts maintain a target range of $55 to $88, with an average of $68.19.
Procore Shares Rise After Cantor Overweight Endorsement. Cantor Fitzgerald reaffirmed its overweight stance on Procore Technologies, keeping a $65 price target. The stock has risen in the market, trading above its 200‑day moving average and near the support level at $55.26. Analysts maintain a target range of $55 to $88, with an average of $68.19.